Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Council For Responsible Nutrition To Defend Weight Loss Claims For Dietary Supplements
In response to a joint citizen’s petition filed by the American Dietetic Association (ADA), The Obesity Society, Shaping America’s Health and GlaxoSmithKline Consumer Healthcare, LP, which asks the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims, the Council for Responsible Nutrition (CRN) responds: "CRN plans to oppose this petition to re-classify weight loss claims as either disease claims or health claims requiring FDA approval. We believe weight loss claims are legitimate and appropriate claims for products in the dietary supplement category, provided these products have substantiation to support the truthfulness of these claims.....
- Council For Responsible Nutrition To Defend Weight Loss Claims For Dietary Supplements
In response to a joint citizen’s petition filed by the American Dietetic Association (ADA), The Obesity Society, Shaping America’s Health and GlaxoSmithKline Consumer Healthcare, LP, which asks the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims, the Council for Responsible Nutrition (CRN) responds: "CRN plans to oppose this petition to re-classify weight loss claims as either disease claims or health claims requiring FDA approval. We believe weight loss claims are legitimate and appropriate claims for products in the dietary supplement category, provided these products have substantiation to support the truthfulness of these claims.....
- Council For Responsible Nutrition To Defend Weight Loss Claims For Dietary Supplements
In response to a joint citizen’s petition filed by the American Dietetic Association (ADA), The Obesity Society, Shaping America’s Health and GlaxoSmithKline Consumer Healthcare, LP, which asks the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims, the Council for Responsible Nutrition (CRN) responds: "CRN plans to oppose this petition to re-classify weight loss claims as either disease claims or health claims requiring FDA approval. We believe weight loss claims are legitimate and appropriate claims for products in the dietary supplement category, provided these products have substantiation to support the truthfulness of these claims.....
- FDA Embarks on Major Hiring Initiative for its Public Health Mission
The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency's responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics and products that emit radiation.
- FDA Embarks on Major Hiring Initiative for its Public Health Mission
The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency's responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics and products that emit radiation.
- FDA Embarks on Major Hiring Initiative for its Public Health Mission
The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency's responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics and products that emit radiation.
- FDA Embarks on Major Hiring Initiative for its Public Health Mission
The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency's responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics and products that emit radiation.
- FDA Completes Final Analysis of "Total Body Formula" and "Total Body Mega Formula" Products
The U.S. Food and Drug Administration’s final analysis of certain flavors of "Total Body Formula" and "Total Body Mega Formula” has detected hazardous amounts of chromium in addition to selenium.
- FDA Completes Final Analysis of "Total Body Formula" and "Total Body Mega Formula" Products
The U.S. Food and Drug Administration’s final analysis of certain flavors of "Total Body Formula" and "Total Body Mega Formula” has detected hazardous amounts of chromium in addition to selenium.
- FDA Completes Final Analysis of "Total Body Formula" and "Total Body Mega Formula" Products
The U.S. Food and Drug Administration’s final analysis of certain flavors of "Total Body Formula" and "Total Body Mega Formula” has detected hazardous amounts of chromium in addition to selenium.
- FDA Completes Final Analysis of "Total Body Formula" and "Total Body Mega Formula" Products
The U.S. Food and Drug Administration’s final analysis of certain flavors of "Total Body Formula" and "Total Body Mega Formula” has detected hazardous amounts of chromium in addition to selenium.
- AHPA Requests OEHHA Withdraw Proposed Prop 65 Language on Beneficial Nutrients
The American Herbal Products Association (AHPA) has submitted comments to the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) requesting the office withdraw its proposed regulatory language on Proposition 65 warnings for chemicals that are both “beneficial to human health” and known by the state of California to cause cancer or reproductive toxicity.
- AHPA Requests OEHHA Withdraw Proposed Prop 65 Language on Beneficial Nutrients
The American Herbal Products Association (AHPA) has submitted comments to the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) requesting the office withdraw its proposed regulatory language on Proposition 65 warnings for chemicals that are both “beneficial to human health” and known by the state of California to cause cancer or reproductive toxicity.
- AHPA Requests OEHHA Withdraw Proposed Prop 65 Language on Beneficial Nutrients
The American Herbal Products Association (AHPA) has submitted comments to the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) requesting the office withdraw its proposed regulatory language on Proposition 65 warnings for chemicals that are both “beneficial to human health” and known by the state of California to cause cancer or reproductive toxicity.
- AHPA Requests OEHHA Withdraw Proposed Prop 65 Language on Beneficial Nutrients
The American Herbal Products Association (AHPA) has submitted comments to the California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) requesting the office withdraw its proposed regulatory language on Proposition 65 warnings for chemicals that are both “beneficial to human health” and known by the state of California to cause cancer or reproductive toxicity.
- Sabinsa Notifies Alchem As To Status of Its Forskohlin [ForsLean(R)] Patent
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin [ForsLean(R)], and has demanded that Alchem cease any activities that mislead the public.
- Sabinsa Notifies Alchem As To Status of Its Forskohlin [ForsLean(R)] Patent
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin [ForsLean(R)], and has demanded that Alchem cease any activities that mislead the public.
- Farrah Marfatia Joins dicentra
In line with dicentra’s expansion into pharmaceutical and international regulatory services, Farrah Marfatia joins dicentra as a regulatory affairs associate, bringing expertise in strategy and filing of over-the-counter (OTC) drug submissions, including Rx-to-OTC Switch, New Drug, and Provincial Scheduling Submissions.
- Farrah Marfatia Joins dicentra
In line with dicentra’s expansion into pharmaceutical and international regulatory services, Farrah Marfatia joins dicentra as a regulatory affairs associate, bringing expertise in strategy and filing of over-the-counter (OTC) drug submissions, including Rx-to-OTC Switch, New Drug, and Provincial Scheduling Submissions.
- Farrah Marfatia Joins dicentra
In line with dicentra’s expansion into pharmaceutical and international regulatory services, Farrah Marfatia joins dicentra as a regulatory affairs associate, bringing expertise in strategy and filing of over-the-counter (OTC) drug submissions, including Rx-to-OTC Switch, New Drug, and Provincial Scheduling Submissions.
- Farrah Marfatia Joins dicentra
In line with dicentra’s expansion into pharmaceutical and international regulatory services, Farrah Marfatia joins dicentra as a regulatory affairs associate, bringing expertise in strategy and filing of over-the-counter (OTC) drug submissions, including Rx-to-OTC Switch, New Drug, and Provincial Scheduling Submissions.
- AHD Luravida™ Omega 3 Cranberry Oil Receives GRAS Approval
AHD International has announced that, based on an independent and collective scientific evaluation, an Expert Panel has concluded that AHD’s Luravida™ Omega 3 Cranberry Seed Oil, produced in accordance with current GMP, has been GRAS (generally accepted as safe) approved.
- AHD Luravida™ Omega 3 Cranberry Oil Receives GRAS Approval
AHD International has announced that, based on an independent and collective scientific evaluation, an Expert Panel has concluded that AHD’s Luravida™ Omega 3 Cranberry Seed Oil, produced in accordance with current GMP, has been GRAS (generally accepted as safe) approved.
- AHD Luravida™ Omega 3 Cranberry Oil Receives GRAS Approval
AHD International has announced that, based on an independent and collective scientific evaluation, an Expert Panel has concluded that AHD’s Luravida™ Omega 3 Cranberry Seed Oil, produced in accordance with current GMP, has been GRAS (generally accepted as safe) approved.
- AHD Luravida™ Omega 3 Cranberry Oil Receives GRAS Approval
AHD International has announced that, based on an independent and collective scientific evaluation, an Expert Panel has concluded that AHD’s Luravida™ Omega 3 Cranberry Seed Oil, produced in accordance with current GMP, has been GRAS (generally accepted as safe) approved.
- NSF's Dietary Supplement Standard is Updated to Keep Pace with FDA GMP Regulations
NSF International has announced that the 2008 version of NSF's American National Standard for Dietary Supplements now includes new good manufacturing practices (GMP) requirements to ensure consistency with the U. S. Food and Drug Administration's (FDA) regulations.
- NSF's Dietary Supplement Standard is Updated to Keep Pace with FDA GMP Regulations
NSF International has announced that the 2008 version of NSF's American National Standard for Dietary Supplements now includes new good manufacturing practices (GMP) requirements to ensure consistency with the U. S. Food and Drug Administration's (FDA) regulations.
- Natural health products: neither food nor drugs - Association calls for the amendment of Bill C-51
The Canadian Health Food Association is asking federal parliamentarians to make good on a promise made 10 years ago when reviewing legislation to amend the current Food & Drugs Act or Bill C-51. Tabled April 8, Bill C-51 is intended to modernize Canada’s regulatory system for foods, drugs, and cosmetics, which hasn’t seen a major review since 1953.
- Natural health products: neither food nor drugs - Association calls for the amendment of Bill C-51
The Canadian Health Food Association is asking federal parliamentarians to make good on a promise made 10 years ago when reviewing legislation to amend the current Food & Drugs Act or Bill C-51. Tabled April 8, Bill C-51 is intended to modernize Canada’s regulatory system for foods, drugs, and cosmetics, which hasn’t seen a major review since 1953.
- Natural health products: neither food nor drugs - Association calls for the amendment of Bill C-51
The Canadian Health Food Association is asking federal parliamentarians to make good on a promise made 10 years ago when reviewing legislation to amend the current Food & Drugs Act or Bill C-51. Tabled April 8, Bill C-51 is intended to modernize Canada’s regulatory system for foods, drugs, and cosmetics, which hasn’t seen a major review since 1953.
- China labelling guidelines could foster industry self-regulation
China’s new nutrition labelling guidelines for pre-packaged foods which come into force this month could kick-start industry self-regulation, an industry consultant from EAS Asia has said.
- China labelling guidelines could foster industry self-regulation
China’s new nutrition labelling guidelines for pre-packaged foods which come into force this month could kick-start industry self-regulation, an industry consultant from EAS Asia has said.
- CHFA Lobbying Hard to Amend Current Bill C-51
The Canadian Health Food Association (CHFA) has launched a postcard lobby campaign to build on the association’s recent advocacy efforts aimed at addressing member concerns about Bill C-51.
- CHFA Lobbying Hard to Amend Current Bill C-51
The Canadian Health Food Association (CHFA) has launched a postcard lobby campaign to build on the association’s recent advocacy efforts aimed at addressing member concerns about Bill C-51.
- CHFA Lobbying Hard to Amend Current Bill C-51
The Canadian Health Food Association (CHFA) has launched a postcard lobby campaign to build on the association’s recent advocacy efforts aimed at addressing member concerns about Bill C-51.
- NutraCea Announces USDA Approval of the Use of Stabilized Rice Bran as an 'Enhancer' to Certain Meat Products
NutraCea (NTRZ) has announced that the Company has received approval from the Food Safety Inspection Service (FSIS), a subsidiary of the United States Department of Agriculture (USDA), to provide its SRB as an "enhancer" to food companies that prepare comminuted meat and poultry products.
- NutraCea Announces USDA Approval of the Use of Stabilized Rice Bran as an 'Enhancer' to Certain Meat Products
NutraCea (NTRZ) has announced that the Company has received approval from the Food Safety Inspection Service (FSIS), a subsidiary of the United States Department of Agriculture (USDA), to provide its SRB as an "enhancer" to food companies that prepare comminuted meat and poultry products.
- NutraCea Announces USDA Approval of the Use of Stabilized Rice Bran as an 'Enhancer' to Certain Meat Products
NutraCea (NTRZ) has announced that the Company has received approval from the Food Safety Inspection Service (FSIS), a subsidiary of the United States Department of Agriculture (USDA), to provide its SRB as an "enhancer" to food companies that prepare comminuted meat and poultry products.
- NutraCea Announces USDA Approval of the Use of Stabilized Rice Bran as an 'Enhancer' to Certain Meat Products
NutraCea (NTRZ) has announced that the Company has received approval from the Food Safety Inspection Service (FSIS), a subsidiary of the United States Department of Agriculture (USDA), to provide its SRB as an "enhancer" to food companies that prepare comminuted meat and poultry products.
- NutraCea Announces USDA Approval of the Use of Stabilized Rice Bran as an 'Enhancer' to Certain Meat Products
NutraCea (NTRZ) has announced that the Company has received approval from the Food Safety Inspection Service (FSIS), a subsidiary of the United States Department of Agriculture (USDA), to provide its SRB as an "enhancer" to food companies that prepare comminuted meat and poultry products.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- EU Regulatory developments could play role in defining international trends
Europe is fast becoming the world’s leading exporter of regulation as authorities in many countries increasingly look for models on which to base their legislation, Simon Pettman, Director of international food and nutrition policy consultancy EAS, has said.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- IADSA celebrates decade of global regulatory achievements
The International Alliance of Dietary/Food Supplement Associations (IADSA) this year celebrates ten years of helping to shape policies and regulations on dietary supplements across the globe.
- Jury Rules in Glycoproducts International, Inc. Patent Case
Glycoproducts International, Inc. has announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated’s (Nasdaq: MTEX) patents relating to Mannatech’s AMBROTOSE® technology.
- Jury Rules in Glycoproducts International, Inc. Patent Case
Glycoproducts International, Inc. has announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated’s (Nasdaq: MTEX) patents relating to Mannatech’s AMBROTOSE® technology.
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- FDA Requests Recall of Xiadafil VIP Tabs
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims
GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- CHFA Comments on Health Canada’s Ten Year Plan to Strengthen Health Care in Canada
Yesterday, the Canadian Health Food Association (CHFA) appeared before the House of Commons Standing Committee on Health with respect to their study on the statutory review of the 10 Year Plan to Strengthen Health Care.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- International Pharmaceuticals, Ltd. Issues a Voluntary Recall of all Viril-Ity-Power (VIP) Tabs, a Product Marketed as a Dietary Supplement
International Pharmaceuticals, Ltd. has announced that it is conducting a voluntary recall of all the company’s supplement product sold under the brand name of Viril-Ity-Power (VIP) Tabs, 560mg/serving, after being informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of a sample from one lot of the product revealed that it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil.
- Workshop highlights dietary supplement regulation in Mexico
More than 100 Mexican and European Union (EU) regulators and experts came together at a workshop on May 6, to discuss and debate issues from the definition of food supplements and the criteria for setting maximum levels of vitamins and minerals, to the use of nutrition and health claims.
- Workshop highlights dietary supplement regulation in Mexico
More than 100 Mexican and European Union (EU) regulators and experts came together at a workshop on May 6, to discuss and debate issues from the definition of food supplements and the criteria for setting maximum levels of vitamins and minerals, to the use of nutrition and health claims.
- NSF International to Host Special Dietary Supplement GMP Training in China
To assist manufacturers and distributors in China with the implementation of the new regulations, NSF today announced that it will be holding a special Good Manufacturing Practices (GMP) training seminar for the dietary supplement industry, Tuesday, June 24th, 2008 from 9:00 AM - 5:00 PM at NSF’s Shanghai Office.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
Health claims regulation across Asia and the EU will be the focus of an upcoming three-hour intensive seminar hosted by international food and nutrition policy consultancy EAS Asia.
The seminar, titled ‘Clarifying Health Claims: Planning regulatory strategies for marketing food supplements and functional foods across key world markets’, aims to guide companies through the key aspects to consider when planning regional and international regulatory strategies in these markets.
Taking place in Singapore on Tuesday June 10 the seminar, which is already attracting regulatory bodies and senior officials in the region, will cover the rules, opportunities and challenges for claims made on products in key Asian markets, across the European Union and in the United States (US).
Speakers Daniel Tsi, Regional Director of EAS Asia, and EAS Europe Food Law Manager Patrick Coppens, will also offer tips for successful international regulatory strategies, showing examples of company successes and challenges.
“The current regulatory environment in Asia alone is diverse and challenging both for companies and regulatory authorities,” said Dr Tsi. “The ASEAN countries are actively working to achieve regulatory harmonisation for health supplement products. This half day seminar provides a not-to-be missed opportunity for different stakeholders to meet, get updated and discuss on the claim regulatory environment in key Asia markets as well as Europe and US.”
Mr Tsi will give an overview of the growing trend towards health claims regulation in the Asian region, highlighting key ASEAN markets, including China and Taiwan. He will also explain the current and future impact of these new legislations on the region’s food and nutritional sector. Mr Coppens will give insight into the workings and implications of the European Union’s Nutrition and Health Claims Regulation, and compare how this fares alongside the rules and regulations currently in place in the US.
Attendance is limited in order to maximize value for the participants. For the full seminar programme or to register for the event, visit www.eas-asia.com
ENDS
EAS provides strategic consulting advice on European, Asian and international regulation on food and nutritional products. It provides companies with regulatory and strategic advice for the marketing and approval of their products in Europe and Asia. EAS also advises governments, trade associations and companies on the impact of European, Asian and global policy.
EAS has offices in Brussels, Italy and Singapore. EAS Italy is a branch of EAS Europe located in northern Italy to follow EFSA developments in Parma closely.
For more information on EAS Europe contact EAS, 50 Rue de l’Association, 1000 Brussels, tel: (+32) (0) 2 218 14 70, email info@eas.eu or visit www.eas.eu. For information on EAS Asia contact EAS Strategic Advice Pte Ltd, 3 Killiney Road, 07-04 Winsland House I, Singapore 239519, tel: (+65) 68 38 12 70, email: info@eas-asia.com or visit www.eas-asia.com |